Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

MedWellAI (MWAI) EBITDA Margin (2017 - 2025)

Historic EBITDA Margin for MedWellAI (MWAI) over the last 9 years, with Q3 2025 value amounting to 330.64%.

  • MedWellAI's EBITDA Margin rose 507313800.0% to 330.64% in Q3 2025 from the same period last year, while for Sep 2025 it was 413.04%, marking a year-over-year decrease of 6095900.0%. This contributed to the annual value of 472.23% for FY2025, which is N/A changed from last year.
  • Per MedWellAI's latest filing, its EBITDA Margin stood at 330.64% for Q3 2025, which was up 507313800.0% from 595.95% recorded in Q2 2025.
  • MedWellAI's EBITDA Margin's 5-year high stood at 51.08% during Q1 2024, with a 5-year trough of 51062.02% in Q3 2024.
  • In the last 5 years, MedWellAI's EBITDA Margin had a median value of 172.23% in 2022 and averaged 3072.62%.
  • As far as peak fluctuations go, MedWellAI's EBITDA Margin crashed by -502068500bps in 2024, and later skyrocketed by 507313800bps in 2025.
  • Over the past 5 years, MedWellAI's EBITDA Margin (Quarter) stood at 13.03% in 2021, then plummeted by -1166bps to 164.91% in 2022, then soared by 88bps to 19.42% in 2023, then tumbled by -2483bps to 501.65% in 2024, then soared by 34bps to 330.64% in 2025.
  • Its last three reported values are 330.64% in Q3 2025, 595.95% for Q2 2025, and 286.02% during Q1 2025.